Prostanoid |
LIPID_ID | PR0021 |
CHEM_NA | 7-[3(R),5(S)-DIHYDROXY-2(R)-(3(S)-HYDROXY-1(E) |
-OCTENYL)CYCLOPENTAN-1(R)-YL]-6-OXOHEPTA |
NOIC ACID |
COMMON_NA | 6-KETOPROSTAGLANDIN F1α |
MOL_FORMULA | C20H36O6 |
MOL_WT | 372 |
MELT_PT |
BOIL_PT |
OPT_ROT | [α]21/D -9.6゚ C1.04 MEOH(070) |
REFRA_IND |
DENSITY |
SOLUBILITY | MEOH,ACETONE,ETHYL ACETATE(070) |
UV_SPEC |
IR_SPEC | NEAT:ν3400,1715,1245,1045,975,915,875,845,800,7 |
30 cm-1 (070) |
NMR_SPEC | 1H-NMR(ACETONE-D6):δ6.1-5.4(bs,4H),5.5-5.2(m, |
2H),4.7-3.5(m,3H),2.5-1.1(m,22H),0.86(t,3H) |
MS_SPEC | METHYL ESTER |
;366(M+-18),348,335,330,323,319,279,265,223,196,1 |
95,164,143, 121,111,99,95,71 (070) DIRECT |
EXPOSURE AMMONIA CI |
POSITIVE:370,353,244,163,153,136, |
NEGATIVE:368,351,334,316,225,219,166, 135,127 |
NOTE_SPEC |
SOURCE | 動物の血管にPGI2の合成酵素が存在し,刺激に応じて |
新規に合成されたものが,非酵素的に分解して6ーケトーP |
GF1αとなる. |
BIOL_ACTIV | 明かな生物活性は報告されていない. |
NOTE |
1998年7月17日 | 16 / 70 ページ |